Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi TNJONE Pharmaceutical
Xi'an, Shaanxi, Chinatnjone.com ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
TNJONE is a large-scale exporter and supplier of pharmaceutical raw materials, peptides, APIs, veterinary pharmaceuticals, and cosmetic/food/feed additives, supplying both animal and human health industries worldwide. While it does not develop originator drugs or have novel clinical trial assets, it is a key manufacturer for a large portfolio of ingredients—including bulk APIs like semaglutide, liraglutide, tirzepatide, and cosmetic peptides—primarily serving as an ingredient source for other drug/formulation companies.
- Therapeutic areas
- CardiovascularEndocrinologyInfectious DiseasesMetabolic DisordersDermatologyOncology
- Modalities
- Small moleculePeptidesRecombinant proteinVitamins
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Shaanxi TNJONE Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shaanxi TNJONE Pharmaceutical.